Qingdao Baheal Medical INC. (301015) — Capital Reinvestment Ratio
Qingdao Baheal Medical INC. (301015) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥230.38 Million) in capital expenditures (CN¥107.50 Million). See how much free cash does Qingdao Baheal Medical INC. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Baheal Medical INC. Capital Reinvestment Ratio (2018–2025)
This chart tracks Qingdao Baheal Medical INC.'s Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Baheal Medical INC. from 2018 to 2025. For live market cap and broader valuation context, see 301015 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥934.45 Million | CN¥288.93 Million | ▼ -17.2% |
| 2024 | 0.37x | CN¥813.85 Million | CN¥303.99 Million | ▲ +61.0% |
| 2023 | 0.23x | CN¥799.50 Million | CN¥185.49 Million | ▼ -32.6% |
| 2022 | 0.34x | CN¥305.75 Million | CN¥105.32 Million | ▲ +127.2% |
| 2021 | 0.15x | CN¥181.30 Million | CN¥27.49 Million | ▲ +135.9% |
| 2019 | 0.06x | CN¥45.96 Million | CN¥2.95 Million | ▼ -77.3% |
| 2018 | 0.28x | CN¥55.50 Million | CN¥15.74 Million | — |